<DOC>
	<DOCNO>NCT00860353</DOCNO>
	<brief_summary>The purpose study determine well tolerate safe AZD2551 different dose level healthy , non-smoking male . It also investigate quickly AZD2551 absorb clear body</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability Pharmacokinetics Single Doses ofAZD2551</brief_title>
	<detailed_description />
	<criteria>Provision sign , write date informed consent prior study specific procedure Be willing use barrier method contraception unless partner postmenopausal , surgically sterile use accepted contraceptive method Have body mass index 18 30 kg/m2 inclusive weight least 50kg 100kg Use prescribe nonprescribed medication two week prior administration study drug History presence condition know interfere absorption , distribution , metabolism excretion drug Any impairment kidney function laboratory result marker kidney function outside reference range consider clinically significant Underlying musculoskeletal symptom unknown origin , subject shoulder girdle musculoskeletal symptom Dupuytrens syndrome</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Single Ascending Dose</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>AZD2551</keyword>
	<keyword>Healthy Volunteer Study</keyword>
</DOC>